Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaojuan Ou
Observed names:
Ou Xiaojuan,
Ou, Xiaojuan,
X J Ou,
Xiao Juan Ou,
Xiao-Juan Ou,
Xiao-juan Ou
show all 6
Institutions:
Capital Medical University,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
Observed institutions:
Capital Medical University,
Peking Union Medical College Hospital,
National Clinical Research Center for Digestive Diseases,
Beijing Friendship Hospital
ORCID:
0009-0002-4662-4970
Observed ORCID:
0009-0002-4662-4970
OpenAlex ID:
A5112731247
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
2016
·
Yameng Sun
, Jialing Zhou
, et al.
·
Hepatology
·
182
Systematic review and meta‐analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population
2019
·
Tingting Lv
, Min Li
, et al.
·
Journal of Gastroenterology and Hepatology
·
156
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
2020
·
Yameng Sun
, Xiaoning Wu
, et al.
·
Clinical Gastroenterology and Hepatology
·
154
PDF
The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease
2019
·
Yiwen Shi
, Qianyi Wang
, et al.
·
Journal of Clinical Gastroenterology
·
100
Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis
2019
·
Na Zeng
, Weijia Duan
, et al.
·
Hepatology International
·
81
OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis
2018
·
Guangyong Sun
, Hua Jin
, et al.
·
Cell Reports
·
62
PDF
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in HBV ‐related compensated cirrhosis
2017
·
Shanshan Wu
, Yuanyuan Kong
, et al.
·
Liver International
·
49
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
2020
·
Min Li
, Tingting Lv
, et al.
·
Hepatology International
·
47
Histological assessment based on liver biopsy: the value and challenges in NASH drug development
2022
·
Xiao-fei Tong
, Qian-yi Wang
, et al.
·
Acta Pharmacologica Sinica
·
46
PDF
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
2018
·
Yameng Sun
, Jialing Zhou
, et al.
·
Scientific Reports
·
45
PDF
An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma
2015
·
Yu Hong
, Jiang Long
, et al.
·
EBioMedicine
·
44
PDF
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis
2019
·
Qianyi Wang
, Hong You
, et al.
·
Hepatology International
·
41
HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation
2021
·
Yandi Xie
, Minghui Li
, et al.
·
Journal of Gastroenterology
·
40
PDF
A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China
2018
·
Wei Zhang
, Anjian Xu
, et al.
·
Liver International
·
40
Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants
2018
·
Tingxia Lv
, Wei Zhang
, et al.
·
Journal of Medical Genetics
·
40
Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
2019
·
Qian Zhang
, Zhiqiang Liu
, et al.
·
Gastroenterology Research and Practice
·
39
PDF
A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury
2020
·
Qiuju Tian
, Ruiyuan Yang
, et al.
·
Clinical Gastroenterology and Hepatology
·
38
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir
2019
·
Yuanyuan Kong
, Yameng Sun
, et al.
·
Journal of Viral Hepatitis
·
38
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
2023
·
Yameng Sun
, Wei Chen
, et al.
·
Clinical Gastroenterology and Hepatology
·
34
Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
2018
·
Weijia Duan
, Xiaojuan Ou
, et al.
·
Revista Española de Enfermedades Digestivas
·
34
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study
2018
·
Xiaoning Wu
, Yiwen Shi
, et al.
·
Expert Opinion on Biological Therapy
·
32
Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
2015
·
Jieyao Cheng
, Jinlin Hou
, et al.
·
PLoS ONE
·
31
PDF
Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis
2015
·
Wen Tang
, Yu Wang
, et al.
·
European Journal of Gastroenterology & Hepatology
·
31
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding
2023
·
Zhiying He
, Bingqiong Wang
, et al.
·
Hepatology International
·
28
Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma
2021
·
Xiaojin Li
, Yanmeng Li
, et al.
·
OncoImmunology
·
27
PDF
Show more works
View as search
Works count:
148
Citation count:
2,442
H-index:
27
I10-index:
66
Year
Topic
Type